2HA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Spero Therapeutics Inc

Watchlist Manager

Watchlist

Price: 32.762 EUR -0.01% Market Closed

Market Cap: €1.9B

S	Spero Therapeutics Inc SWB:2HA	US
M	Merck & Co Inc XMUN:6MK	US
	Italmobiliare SpA OTC:IMSMF	IT
F	Flowers Foods Inc F:FWF	US
S	Shaftesbury Capital PLC F:C20	UK
O	Odakyu Electric Railway Co Ltd DUS:V8H	JP
	Astellas Pharma Inc F:YPHA	JP
N	National Retail Properties Inc F:CZ2	US
B	Banco BPM SpA SWB:BPM	IT
	Boozt AB F:BOK	SE
	Metal Powder Works Ltd F:3OV	AU
	ENKA Insaat ve Sanayi AS F:ENP	TR

Profitability Summary

Spero Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Healthy Operating Margin

14%

Negative 3Y Average Operating Margin

-40%

Operating Margin is Increasing

3% > 14%

Healthy Net Margin

16%

Negative 3Y Average Net Margin

-37%

Net Margin is Increasing

-2% > 16%

Exceptional Free Cash Flow Margin

42%

Negative 3Y Average Free Cash Flow Margin

-27%

Free Cash Flow Margin is Increasing

37% > 42%

Positive ROE

19%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-20%

ROIC is Increasing

-48% > 41%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.